clonazepam has been researched along with Facial Pain in 5 studies
Clonazepam: An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses.
clonazepam : 1,3-Dihydro-2H-1,4-benzodiazepin-2-one in which the hydrogens at positions 5 and 7 are substituted by 2-chlorophenyl and nitro groups, respectively. It is used in the treatment of all types of epilepsy and seizures, as well as myoclonus and associated abnormal movements, and panic disorders. However, its use can be limited by the development of tolerance and by sedation.
Facial Pain: Pain in the facial region including orofacial pain and craniofacial pain. Associated conditions include local inflammatory and neoplastic disorders and neuralgic syndromes involving the trigeminal, facial, and glossopharyngeal nerves. Conditions which feature recurrent or persistent facial pain as the primary manifestation of disease are referred to as FACIAL PAIN SYNDROMES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martin, WJ | 1 |
| Forouzanfar, T | 1 |
| Forssell, H | 1 |
| Teerijoki-Oksa, T | 1 |
| Kotiranta, U | 1 |
| Kantola, R | 1 |
| Bäck, M | 1 |
| Vuorjoki-Ranta, TR | 1 |
| Siponen, M | 1 |
| Leino, A | 1 |
| Puukka, P | 1 |
| Estlander, AM | 1 |
| Gremeau-Richard, C | 1 |
| Woda, A | 2 |
| Navez, ML | 2 |
| Attal, N | 1 |
| Bouhassira, D | 1 |
| Gagnieu, MC | 1 |
| Laluque, JF | 1 |
| Picard, P | 2 |
| Pionchon, P | 1 |
| Tubert, S | 1 |
| Gremeau, C | 1 |
| Pichard-Leandri, E | 1 |
| Hampf, G | 1 |
| Kuoppasalmi, K | 1 |
| Henriksson, M | 1 |
| Achté, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Use of Low Intensity Laser Combined With Topical Clonazepam for the Treatment of Burning Mouth Syndrome[NCT04313907] | Phase 4 | 27 participants (Anticipated) | Interventional | 2019-08-16 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for clonazepam and Facial Pain
| Article | Year |
|---|---|
The efficacy of anticonvulsants on orofacial pain: a systematic review.
Topics: Amines; Anticonvulsants; Burning Mouth Syndrome; Carbamazepine; Clonazepam; Cyclohexanecarboxylic Ac | 2011 |
2 trials available for clonazepam and Facial Pain
| Article | Year |
|---|---|
Topical clonazepam in stomatodynia: a randomised placebo-controlled study.
Topics: Administration, Topical; Aged; Anticonvulsants; Burning Mouth Syndrome; Clonazepam; Double-Blind Met | 2004 |
A possible therapeutic solution for stomatodynia (burning mouth syndrome).
Topics: Adult; Aged; Aged, 80 and over; Burning Mouth Syndrome; Clonazepam; Facial Pain; Female; GABA Modula | 1998 |
2 other studies available for clonazepam and Facial Pain
| Article | Year |
|---|---|
Pain and pain behavior in burning mouth syndrome: a pain diary study.
Topics: Adaptation, Psychological; Analgesics; Analysis of Variance; Anticonvulsants; Antidepressive Agents, | 2012 |
Chronic facial pain together with severe depression is responsive to electroconvulsive therapy. A case report.
Topics: Amitriptyline; Chronic Disease; Clonazepam; Depressive Disorder; Electroconvulsive Therapy; Facial P | 1992 |